Healio

Treatment adherence higher with testosterone undecanoate vs. testosterone cypionate

Please provide your email address to receive an email when new articles are posted on . Men prescribed long-acting testosterone undecanoate injections had a higher adherence to therapy at 1 year ...
ascopubs.org

Prostate cancer incidence in hypogonadal men on long-term treatment with testosterone undecanoate injections.

18F-fluorocholine positron emission tomography/computed tomography for early outcome prediction in metastatic castration-resistant prostate cancer patients treated with enzalutamide: A ...
ascopubs.org

Incidence and severity of prostate cancer in 375 hypogonadal men treated with testosterone undecanoate injections (TU) for up to 10 years and 296 untreated hypogonadal controls.

Association of polymorphism in YB-1 regulating androgen receptor V7 expression with efficacy of androgen-deprivation therapy in metastatic prostate cancer. This is an ASCO Meeting Abstract from the ...
Medical Xpress

Study finds oral testosterone therapy undecanoate is effective, with no liver toxicity

An industry-supported study of an oral testosterone replacement therapy (TRT), testosterone undecanoate (TU, brand name Jatenzo) finds it is an effective, long-term treatment for men with low ...
Nasdaq

Tolmar Announces Acquisition of JATENZO® (testosterone undecanoate) for the Treatment of Hypogonadism to Expand its Market Leading Urology Portfolio

- Launched in 2020, JATENZO was the first oral softgel testosterone medicine approved in the US by the FDA in more than 60 years- JATENZO is an oral softgel testosterone undecanoate for testosterone ...
Healio

New testosterone therapies offer options for men with hypogonadism

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Three new testosterone therapies offer innovative drug delivery options for men with hypogonadism ...
FierceBiotech

Endo Pharmaceuticals Provides Regulatory Update On AVEED™ (Testosterone Undecanoate) Injection

MALVERN, Pa., May 30, 2013 /PRNewswire/ -- Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP) announced today that the U.S. Food and Drug Administration (FDA) has ...
Medical Xpress

11 years of data add to the evidence for using testosterone therapy to treat obesity

New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), ...
Reuters

New oral testosterone undecanoate formulation restores normal testosterone levels

NEW YORK (Reuters Health) - A new oral testosterone undecanoate formulation can restore testosterone concentrations to normal in hypogonadal men, researchers report. "Effective as other testosterone ...
Medscape

Large Study Finds Trans Men on Testosterone at Risk for Blood Clots

Over 10% of transgender men (females transitioning to male) who take testosterone develop high hematocrit levels that could put them at greater risk for a thrombotic event, and the largest increase in ...
EurekAlert!

Study finds oral testosterone therapy undecanoate is effective, with no liver toxicity

WASHINGTON--An industry-supported study of an oral testosterone replacement therapy (TRT), testosterone undecanoate (TU, brand name Jatenzo) finds it is an effective, long-term treatment for men with ...